Rachel Saunders-Pullman
The Alan and Barbara Mirken Department of Neurology
Beth Israel Medical Center
10 Union Square East
Suite 5J
Name/email consistency: high
- Olfactory dysfunction in LRRK2 G2019S mutation carriers. Saunders-Pullman, R., Stanley, K., Wang, C., San Luciano, M., Shanker, V., Hunt, A., Severt, L., Raymond, D., Ozelius, L.J., Lipton, R.B., Bressman, S.B. Neurology (2011)
- Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization. Saunders-Pullman, R., Hagenah, J., Dhawan, V., Stanley, K., Pastores, G., Sathe, S., Tagliati, M., Condefer, K., Palmese, C., Brüggemann, N., Klein, C., Roe, A., Kornreich, R., Ozelius, L., Bressman, S. Mov. Disord. (2010)
- LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Saunders-Pullman, R., Barrett, M.J., Stanley, K.M., Luciano, M.S., Shanker, V., Severt, L., Hunt, A., Raymond, D., Ozelius, L.J., Bressman, S.B. Mov. Disord. (2010)
- Validity of spiral analysis in early Parkinson's disease. Saunders-Pullman, R., Derby, C., Stanley, K., Floyd, A., Bressman, S., Lipton, R.B., Deligtisch, A., Severt, L., Yu, Q., Kurtis, M., Pullman, S.L. Mov. Disord. (2008)
- Narrowing the DYT6 dystonia region and evidence for locus heterogeneity in the Amish-Mennonites. Saunders-Pullman, R., Raymond, D., Senthil, G., Kramer, P., Ohmann, E., Deligtisch, A., Shanker, V., Greene, P., Tabamo, R., Huang, N., Tagliati, M., Kavanagh, P., Soto-Valencia, J., Aguiar, P.C., Risch, N., Ozelius, L., Bressman, S. Am. J. Med. Genet. A (2007)
- Increased frequency of the LRRK2 G2019S mutation in an elderly Ashkenazi Jewish population is not associated with dementia. Saunders-Pullman, R., Lipton, R.B., Senthil, G., Katz, M., Costan-Toth, C., Derby, C., Bressman, S., Verghese, J., Ozelius, L.J. Neurosci. Lett. (2006)
- A new screening tool for cervical dystonia. Saunders-Pullman, R., Soto-Valencia, J., Costan-Toth, C., Shriberg, J., Raymond, D., Derby, C.A., Lipton, R.B., Bressman, S.B. Neurology (2005)
- Phenylalanine loading as a diagnostic test for DRD: interpreting the utility of the test. Saunders-Pullman, R., Blau, N., Hyland, K., Zschocke, J., Nygaard, T., Raymond, D., Shanker, V., Mohrmann, K., Arnold, L., Tabbal, S., deLeon, D., Ford, B., Brin, M., Chouinard, S., Ozelius, L., Klein, C., Bressman, S.B. Mol. Genet. Metab. (2004)
- Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?. Saunders-Pullman, R. Endocrine (2003)
- Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Saunders-Pullman, R., Shriberg, J., Heiman, G., Raymond, D., Wendt, K., Kramer, P., Schilling, K., Kurlan, R., Klein, C., Ozelius, L.J., Risch, N.J., Bressman, S.B. Neurology (2002)